Amgen (AMGN)

Cost of Revenue

$10.43B

TTM · Period ending: · USD

AMGN logo

AMGN Cost of Revenue

Latest reported$10.43B
AMGN TTM Cost of Revenue ($0.00 → $10.43B)
High-resolution chart · PNG

AMGN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
300,800,000
251,100,000
196,600,000
204,400,000
206,900,000
212,200,000
225,300,000
221,000,000
213,200,000
206,500,000
201,400,000
198,200,000
190,200,000
191,000,000
183,700,000
181,900,000
186,300,000
179,500,000
182,900,000
174,300,000
168,400,000
180,800,000
188,700,000
184,700,000
183,200,000
174,800,000
163,400,000
166,500,000
170,300,000
165,900,000
169,300,000
171,900,000
168,800,000
160,500,000
151,200,000
131,000,000
115,100,000
104,000,000
91,200,000
77,200,000
63,900,000
55,200,000
44,300,000
35,200,000
27,400,000
14,800,000
8,900,000
4,600,000
200,000
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.